Edwards Lifesciences

1 Edwards Way
Irvine, CA 92614

About Edwards Lifesciences

Transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 valve demonstrated 75% lower rates of 30-day all-cause mortality and disabling stroke compared to surgery in intermediate-risk patients.

Competitors of Edwards Lifesciences

Sorin Group

To deliver on our commitments to patients and healthcare providers, Sorin Group teams continue to research, develop, and deliver reliable and state-of-the-art therapeutic solutions that address unmet cardiovascular needs and improve patient outcomes.    Read More

BioStable Science & Engineering, Inc.

BioStable Science and Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease. Read More